Company / Debt per Share
ADMA Biologics, Inc. Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.30
FY2025
5-year range
$0.30 / $0.32
FY2021-FY2025
Trend
-4.7%
vs FY2024
Sector context
#72 of 82
Health Care
What the data says
ADMA Biologics, Inc.'s debt per share of $0.30 is lower than 88% of companies in the Health Care sector (FY2025). Debt per Share has fluctuated over the past 6 years, ranging from $0.00 in FY2019 to $0.32 in FY2024.
Based on SEC 10-K filings.
0.30 in FY2025.
Increased from $0.00 to $0.30 over the past 6 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 82This company $0.30 Sector average $126.59
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 4.7% year-over-year.
- Ranks #72 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2024.
- Lowest debt per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.30 | -4.7% |
| FY2024 | $0.32 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $0.00 | -100.0% |
| FY2018 | $0.08 | -64.9% |
| FY2017 | $0.21 | +28.2% |
| FY2016 | $0.17 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026